Form Health is a telehealth company that specializes in evidence-based obesity care and weight loss management. It offers personalized treatment plans, including lifestyle changes and FDA-approved medications, tailored by board-certified obesity medicine doctors and registered dietitians.

Form Health

Form Health is the national leader in science-based obesity care.  Our clinical care model consists of one-on-one, personalized care from a dedicated ABOM-certified physician and a CSOWM-certified Registered Dietitian, who develop individualized treatment plans that address nutrition, physical activity, mindset shifts, and include a prescription for FDA-approved medication, if appropriate. Form Health keeps safety, efficacy, and outcomes at the forefront as we incorporate the latest research and science into our approach. This means we’re always innovating, constantly getting smarter about the science of obesity care, relentlessly focusing on exceptional results, and calling out harmful practices that hold back progress. The result is life-changing outcomes for our patients and meaningful ROI for our enterprise partners. Form Health is in-network with national health plans. Learn more at formhealth.co.

NextView Ventures

SignalFire

Form Health is thrilled to announce our Series B funding.

Form was founded to fundamentally change the way obesity care is delivered to Americans. We keep safety, efficacy, and outcomes at the forefront as we incorporate the latest research and science into our approach. This means we’re always innovating, constantly getting smarter about the science of obesity care, relentlessly focusing on exceptional results, and calling out harmful practices that hold back progress. The result is life-changing outcomes for our patients and meaningful ROI for our partners.

With the new funding, we’ll be expanding our work with our enterprise partners, including employers, consultants and health plans, deeply investing in product and accelerating the hiring of ABOM-certified physicians to keep up with extraordinary patient demand. 

Thank you to the team at Sound Ventures for partnering with us during this exciting period of our growth, and the folks at M13, SignalFire, and NextView Ventures for continuing to believe in our mission to greatly expand access to science-based obesity care.

FORM CMO Florencia Halperin reinforces the importance of nutritional support for patients taking GLP-1 and GIP receptor agonists. Registered Dietitians can play a critical role in helping patients manage any risk of malnutrition and set sustainable dietary goals during AOM therapy.

At FORM patients receive comprehensive obesity care by working 1:1 with both an ABOM doctor and a CSOWM Registered Dietitian. Want to learn more about our science-based approach? Reach out to employers@formhealth.co.

Form Health physician Nat Pedley shares what it's like to be part of the Form team and how practicing telemedicine provides an opportunity to build meaningful relationships with his patients. Excited about making a difference in healthcare and helping patients reach their weight loss and health goals? Join our team of obesity medicine specialists! Explore our job opportunities: https://lnkd.in/dZUp2V6p

It is great to see studies conducted to help us establish that while obesity treatments lead to weight loss - perhaps even more importantly - they help prevent progression of metabolic disease," says FORM CMO Florencia Halperin.

At Form Health, we treat obesity as a chronic disease with science-based, comprehensive care. Is your organization seeking an impactful and cost-effective solution to address the high cost of obesity and metabolic disease? Contact employers@formhealth.co to learn how we can help.

We are excited for today's Northeast Business Group on Health Annual Health and Wellness Benefits Conference! Don't miss our CMO, Florencia Halperin, who will be speaking on the "GLP-1s: It's Complicated" panel this afternoon.

Interested to learn how FORM can support your organization provide access to clinical obesity care that delivers real results and ROI? Stop by table #4 and connect with Brian Walker at the event or email employers@formhealth.co

Check out FORM Chief Medical Officer Dr. Florencia Halperin's recent post on the latest BCBS Association analysis of GLP-1 treatment trends highlights how the FORM clinical model that connects patients with obesity experts who provide frequent ongoing support contributes to success. Interested in learning more about our evidence-based approach? Reach out to employers@formhealth.co

Metric
Company Name	Form Health
Symbol
MSH ID	CO:FORMHEALTH
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Healthcare
Country	US
Stage
Employee Count	93
Website	formhealth.co
LinkedIn	form-health
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

CO:FORMHEALTH

Form Health

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue